These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Indomethacin responsiveness of patent ductus arteriosus and renal abnormalities in preterm infants treated with indomethacin. Itabashi K, Ohno T, Nishida H. J Pediatr; 2003 Aug; 143(2):203-7. PubMed ID: 12970633 [Abstract] [Full Text] [Related]
10. Comparison of renal effects of ibuprofen versus indomethacin during treatment of patent ductus arteriosus in contiguous historical cohorts. Kushnir A, Pinheiro JM. BMC Clin Pharmacol; 2011 Jun 30; 11():8. PubMed ID: 21718490 [Abstract] [Full Text] [Related]
12. Potential Unintended Consequences of a Conservative Management Strategy for Patent Ductus Arteriosus. Elhoff JJ, Ebeling M, Hulsey TC, Atz AM. Congenit Heart Dis; 2016 Jun 30; 11(1):52-7. PubMed ID: 26193967 [Abstract] [Full Text] [Related]
13. Treatment of patent ductus arteriosus with low-dose indomethacin in very low birth weight neonates with impairment of renal function: report of three cases. Kuo CY. J Perinat Med; 1996 Jun 30; 24(6):657-60. PubMed ID: 9120749 [Abstract] [Full Text] [Related]
19. Oral ibuprofen and indomethacin for treatment of patent ductus arteriosus in premature infants: a randomized trial at Ramathibodi Hospital. Supapannachart S, Limrungsikul A, Khowsathit P. J Med Assoc Thai; 2002 Nov 30; 85 Suppl 4():S1252-8. PubMed ID: 12549803 [Abstract] [Full Text] [Related]
20. Neonatal necrotizing enterocolitis with intestinal perforation in extremely premature infants receiving early indomethacin treatment for patent ductus arteriosus. Fujii AM, Brown E, Mirochnick M, O'Brien S, Kaufman G. J Perinatol; 2002 Nov 30; 22(7):535-40. PubMed ID: 12368968 [Abstract] [Full Text] [Related] Page: [Next] [New Search]